From time to time, the company may offer up to $500M aggregate dollar amount of shares of its common stock or preferred stock, debt securities, warrants to purchase its common stock, preferred stock or debt securities, subscription rights to purchase its common stock, preferred stock or debt securities and/or units consisting of some or all of these securities, in any combination, together or separately, in one or more offerings, in amounts, at prices and on the terms that the company will determine at the time of the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANAB:
- Biotech Alert: Searches spiking for these stocks today
- H.C. Wainwright still ‘optimistic’ on Phase 2 data for AnaptysBio’s rosnilimab
- AnaptysBio weakness on competitor news a buying opportunity, says Guggenheim
- AnaptysBio to be weak on Lilly pulling peresolimab from pipeline, says Stifel
- AnaptysBio sinks 30% after Lilly slides show PD-1 agonist pulled